- Poster presentation
- Open Access
Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
Critical Care volume 17, Article number: P515 (2013)
Data collection was conducted at three hospitals from 2008 to 2011. Patients with any active HM condition were matched with two control patients at two hospitals and with one control at Christie Hospital. Control patients had the same APACHE II (within 2 points) and admission diagnosis, but no HM. Readmissions and planned surgical cases were excluded.
A total of 163 patients with HM were compared with 237 control patients. Seventy-four admissions with HM were identified at two hospitals, and each was matched with two control patients. Eighty-nine admissions with HM from Christie Hospital were identified. These were matched with 89 controls. Patients with HM spent significantly longer in hospital before ICU admission (Table 1). Unit and hospital mortality rates were not statistically different between patients with HM and without HM (Table 2).
Unit mortality of critically ill patients with HM was similar to those without HM. Hospital mortality in patients with HM was higher than those without HM, although not statistically significant. Severity of illness at presentation to critical care is the main determinant of outcome in patients with HM.
Hampshire PA, et al.: Crit Care. 2009, 13: R137. 10.1186/cc8016
Massion PB, et al.: Crit Care Med. 2002, 30: 2260-2270. 10.1097/00003246-200210000-00014
About this article
Cite this article
Pugh, R., Hampshire, P. & Hajimichael, P. Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy. Crit Care 17, P515 (2013). https://doi.org/10.1186/cc12453
- Public Health
- Data Collection
- Mortality Rate
- Emergency Medicine
- Critical Care